Clinical Trial Update: Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial ECCPC evaluating changes in cognition among patients undergoing chemotherapy; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Cognitive Impairment

Snippet

Sponsor: Ellis Medicine | Conditions: Chemotherapy-related Cognitive Impairment | Phase 3 | Status: ENROLLING_BY_INVITATION